Molecular Risk Markers Define Risk of Relapse in Myeloid Leukemia of Down syndrome Beyond Measurable Residual Disease
Blood Adv. 2025 Oct 22:bloodadvances.2025017837. doi: 10.1182/bloodadvances.2025017837. Online ahead of print. ABSTRACT Myeloid leukemia of Down syndrome (ML-DS) is a distinct form of pediatric acute …